Brunn Carsten
SEC insider (Form 3/4/5 filer). CIK 0001760229. President and CEO at Cartesian Therapeutics, Inc. (RNAC). 5 reported Form 4/5 transactions since Sep 2024; latest on Jan 6, 2026. Located in FREDERICK, MD.
Companies Brunn Carsten has filed insider reports for
- Cartesian Therapeutics, Inc. (RNAC): Director, Officer, President and CEO
Brunn Carsten
CIK: 0001760229
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)3 (60.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (40.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RNAC
Cartesian Therapeutics, Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jan 6, 2026RNAC
Cartesian Therapeutics, Inc.
SaleDirect23.8K shares at avg. $6.82$162K - Jan 2, 2026RNAC
Cartesian Therapeutics, Inc.
AwardDirect143.2K shares- - Jan 6, 2025RNAC
Cartesian Therapeutics, Inc.
SaleDirect8.7K shares at avg. $16.83$147K - Jan 3, 2025RNAC
Cartesian Therapeutics, Inc.
SaleDirect8.6K shares at avg. $16.72$143K - Jan 2, 2025RNAC
Cartesian Therapeutics, Inc.
AwardDirect57.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 6, 2026 | RNAC Cartesian Therapeutics, Inc. | Sale | 23,766 | $6.82 | $162,077 | Direct |
| Jan 2, 2026 | RNAC Cartesian Therapeutics, Inc. | Award | 143,200 | - | $0 | Direct |
| Jan 6, 2025 | RNAC Cartesian Therapeutics, Inc. | Sale | 8,708 | $16.83 | $146,575 | Direct |
| Jan 3, 2025 | RNAC Cartesian Therapeutics, Inc. | Sale | 8,563 | $16.72 | $143,190 | Direct |
| Jan 2, 2025 | RNAC Cartesian Therapeutics, Inc. | Award | 57,500 | - | $0 | Direct |
1-5 of 5 transactions